Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine(Vero Cell), Inactivated (Zhejiang Vacin Biomedicine)

双价肾综合征出血热灭活疫苗(Vero细胞)（艾美卫信生物药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemorrhagic Fever with Renal Syndrome Bivalent Vaccine(Vero Cell), Inactivated (Zhejiang Vacin Biomedicine)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fever with Renal Syndrome

Global Approved IndicationsHemorrhagic Fever with Renal Syndrome

Approved Indications in ChinaHemorrhagic Fever with Renal Syndrome

Original Approved Country/TerritoryMainland China

Original Approved Date2007/09/30

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

Inactive CompaniesN/A

Active IndicationsHemorrhagic Fever with Renal Syndrome

Inactive IndicationsN/A

Other Information

ATC CodeJ07BL